10.20.21
Benign Ovarian Cysts a Common Side Effect of mTOR-Inhibitor Therapy
NEW YORK (Reuters Health) – A meta-analysis confirms that ovarian cyst development is a common side effect of treatment with a mammalian target of rapamycin inhibitor (mTORi). In their paper in BMJ Open, the researchers note that the mTOR-signaling pathway regulates ovarian function, so it’s conceivable that mTORi may affect ovarian activity. Observational data suggest